BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 19252482)

  • 1. Toxin B is essential for virulence of Clostridium difficile.
    Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
    Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of toxin A and toxin B in Clostridium difficile infection.
    Kuehne SA; Cartman ST; Heap JT; Kelly ML; Cockayne A; Minton NP
    Nature; 2010 Oct; 467(7316):711-3. PubMed ID: 20844489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain.
    Kuehne SA; Collery MM; Kelly ML; Cartman ST; Cockayne A; Minton NP
    J Infect Dis; 2014 Jan; 209(1):83-6. PubMed ID: 23935202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
    Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
    J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.
    Carter GP; Douce GR; Govind R; Howarth PM; Mackin KE; Spencer J; Buckley AM; Antunes A; Kotsanas D; Jenkin GA; Dupuy B; Rood JI; Lyras D
    PLoS Pathog; 2011 Oct; 7(10):e1002317. PubMed ID: 22022270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
    Secore S; Wang S; Doughtry J; Xie J; Miezeiewski M; Rustandi RR; Horton M; Xoconostle R; Wang B; Lancaster C; Kristopeit A; Wang SC; Christanti S; Vitelli S; Gentile MP; Goerke A; Skinner J; Strable E; Thiriot DS; Bodmer JL; Heinrichs JH
    PLoS One; 2017; 12(1):e0170640. PubMed ID: 28125650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's a SNP between friends: The influence of single nucleotide polymorphisms on virulence and phenotypes of Clostridium difficile strain 630 and derivatives.
    Collery MM; Kuehne SA; McBride SM; Kelly ML; Monot M; Cockayne A; Dupuy B; Minton NP
    Virulence; 2017 Aug; 8(6):767-781. PubMed ID: 27652799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human intestinal enteroids as a model of
    Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
    [No Abstract]   [Full Text] [Related]  

  • 11. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
    Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.
    Mansfield MJ; Tremblay BJ; Zeng J; Wei X; Hodgins H; Worley J; Bry L; Dong M; Doxey AC
    PLoS Pathog; 2020 Dec; 16(12):e1009181. PubMed ID: 33370413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.
    Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H
    Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of flagella in Clostridium difficile pathogenicity.
    Stevenson E; Minton NP; Kuehne SA
    Trends Microbiol; 2015 May; 23(5):275-82. PubMed ID: 25659185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel virulence factor in Clostridium difficile that modulates toxin sensitivity of cultured epithelial cells.
    Miura M; Kato H; Matsushita O
    Infect Immun; 2011 Sep; 79(9):3810-20. PubMed ID: 21746858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences.
    Stabler RA; Dawson LF; Phua LTH; Wren BW
    J Med Microbiol; 2008 Jun; 57(Pt 6):771-775. PubMed ID: 18480336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and elimination of a novel non-toxigenic
    Maslanka JR; Gu CH; Zarin I; Denny JE; Broadaway S; Fett B; Mattei LM; Walk ST; Abt MC
    Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 33305657
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
    Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
    Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a hemorrhagic determinant in
    Zheng Y; Yang Q; Luo J; Zhang Y; Li X; He L; Ma C; Tao L
    Microbiol Spectr; 2024 Jun; 12(6):e0035424. PubMed ID: 38709085
    [No Abstract]   [Full Text] [Related]  

  • 20. Murine Intrarectal Instillation of Purified Recombinant
    Markham NO; Bloch SC; Shupe JA; Laubacher EN; Thomas AK; Kroh HK; Childress KO; Peritore-Galve FC; Washington MK; Coffey RJ; Lacy DB
    Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33468584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 43.